Page last updated: 2024-10-25

ciprofloxacin and Leukemia, Myelomonocytic, Acute

ciprofloxacin has been researched along with Leukemia, Myelomonocytic, Acute in 2 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Leukemia, Myelomonocytic, Acute: A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strobbe, L1
Brüggemann, RJ1
Donnelly, PJ1
Blijlevens, NM1
Pessina, A1
Raimondi, A1
Croera, C1
Acchini, M1
Mineo, E1
Foti, P1
Neri, MG1

Other Studies

2 other studies available for ciprofloxacin and Leukemia, Myelomonocytic, Acute

ArticleYear
A rare case of supraspinatus tendon rupture.
    Annals of hematology, 2012, Volume: 91, Issue:1

    Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Leukemia, Myelomonocytic, Acute; Male; Risk Fact

2012
Altered DNA-cleavage activity of topoisomerase II from WEHI-3B leukemia cells with specific resistance to ciprofloxacin.
    Anti-cancer drugs, 2001, Volume: 12, Issue:5

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; Cipr

2001